Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 [CNBC]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: CNBC
While Novo is bracing for a sales decline, Lilly sees revenue charging ahead thanks to its blockbuster medicines. The split in guidance underscores Lilly's stronger position in the obesity and diabetes drug market, underpinned by its more effective injections and early foray into direct-to-consumer sales. In this article The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters It's a tale of two drugmakers in the red-hot obesity drug market. Both Novo Nordisk and Eli Lilly are grappling with lower prices in the U.S. , but their 2026 outlooks are diverging sharply: While Novo is bracing for a sales decline , Lilly sees revenue jumping again thanks to its blockbuster medicines. The split in guidance – despite similar headwinds – underscores the strength of Lilly's position in the obesity and diabetes drug market, underpinned by its more effective injections and early foray into direct-to-consumer sales, among other factors. While Novo Nordisk effectively ma
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions [Yahoo! Finance]Yahoo! Finance
- Eil Lilly shares jump on strong GLP-1 sales, as Novo Nordisk tumbles [Yahoo! Finance]Yahoo! Finance
- We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat [CNBC]CNBC
- Wall Street Lunch: Washington Post Lays Off A Third Of Staff [Seeking Alpha]Seeking Alpha
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- LLY's page on the SEC website